Kayla Sprenger
Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Dynamics Simulation | 14 | 2026 | 267 | 2.830 |
Why?
| | Receptors, Immunologic | 3 | 2026 | 210 | 2.480 |
Why?
| | Membrane Glycoproteins | 3 | 2026 | 495 | 2.230 |
Why?
| | Antibodies, Neutralizing | 5 | 2025 | 348 | 1.710 |
Why?
| | Ionic Liquids | 4 | 2017 | 7 | 1.600 |
Why?
| | AIDS Vaccines | 2 | 2022 | 53 | 1.420 |
Why?
| | Alzheimer Disease | 3 | 2026 | 641 | 1.150 |
Why?
| | Antibody Affinity | 3 | 2025 | 60 | 1.090 |
Why?
| | Apolipoprotein E4 | 2 | 2026 | 47 | 1.080 |
Why?
| | HIV-1 | 3 | 2022 | 913 | 1.030 |
Why?
| | Microglia | 2 | 2026 | 289 | 0.930 |
Why?
| | Immunoglobulin Heavy Chains | 2 | 2023 | 83 | 0.910 |
Why?
| | Lipid Metabolism | 2 | 2026 | 533 | 0.870 |
Why?
| | Lipoproteins | 1 | 2025 | 165 | 0.820 |
Why?
| | Antibodies, Viral | 2 | 2025 | 689 | 0.810 |
Why?
| | Cellulase | 2 | 2021 | 32 | 0.810 |
Why?
| | Phospholipids | 1 | 2025 | 215 | 0.810 |
Why?
| | Immunoglobulin Light Chains | 1 | 2023 | 52 | 0.750 |
Why?
| | B-Lymphocytes | 2 | 2025 | 887 | 0.700 |
Why?
| | Cellulose | 1 | 2021 | 55 | 0.680 |
Why?
| | Biocatalysis | 2 | 2017 | 68 | 0.600 |
Why?
| | Viral Vaccines | 1 | 2020 | 107 | 0.580 |
Why?
| | Immunization Schedule | 1 | 2020 | 187 | 0.570 |
Why?
| | Protein Binding | 6 | 2025 | 2244 | 0.520 |
Why?
| | Silicon Dioxide | 2 | 2017 | 119 | 0.510 |
Why?
| | Protein Precursors | 1 | 2017 | 127 | 0.500 |
Why?
| | Lipase | 1 | 2017 | 76 | 0.490 |
Why?
| | HIV Infections | 2 | 2022 | 3215 | 0.480 |
Why?
| | Mixed Function Oxygenases | 1 | 2016 | 43 | 0.470 |
Why?
| | Binding Sites | 3 | 2026 | 1309 | 0.470 |
Why?
| | Enzymes | 1 | 2016 | 60 | 0.460 |
Why?
| | Computer Simulation | 2 | 2020 | 1014 | 0.460 |
Why?
| | Thermodynamics | 6 | 2026 | 420 | 0.460 |
Why?
| | Polysaccharides | 1 | 2016 | 88 | 0.460 |
Why?
| | Protein Conformation | 3 | 2025 | 916 | 0.410 |
Why?
| | Peptide Fragments | 1 | 2017 | 693 | 0.390 |
Why?
| | Brain | 1 | 2025 | 2991 | 0.370 |
Why?
| | Antibodies | 2 | 2026 | 400 | 0.360 |
Why?
| | HIV Antibodies | 2 | 2022 | 61 | 0.350 |
Why?
| | Vaccination | 1 | 2020 | 1449 | 0.340 |
Why?
| | Bacterial Proteins | 1 | 2017 | 980 | 0.320 |
Why?
| | Solvents | 2 | 2023 | 112 | 0.310 |
Why?
| | Mutation | 4 | 2026 | 4093 | 0.290 |
Why?
| | Germinal Center | 2 | 2025 | 67 | 0.270 |
Why?
| | Apolipoprotein E3 | 1 | 2026 | 7 | 0.250 |
Why?
| | Neuropilin-1 | 1 | 2026 | 8 | 0.240 |
Why?
| | Placenta Growth Factor | 1 | 2026 | 26 | 0.240 |
Why?
| | Apolipoproteins E | 1 | 2026 | 97 | 0.240 |
Why?
| | Imidazoles | 2 | 2017 | 245 | 0.230 |
Why?
| | Models, Immunological | 1 | 2025 | 100 | 0.220 |
Why?
| | Protein Engineering | 1 | 2026 | 122 | 0.210 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2025 | 134 | 0.210 |
Why?
| | Enzyme Inhibitors | 2 | 2018 | 823 | 0.210 |
Why?
| | Burkholderiales | 1 | 2024 | 6 | 0.200 |
Why?
| | Ligands | 1 | 2026 | 678 | 0.200 |
Why?
| | Adsorption | 2 | 2021 | 154 | 0.200 |
Why?
| | Polyethylene Terephthalates | 1 | 2024 | 21 | 0.200 |
Why?
| | Hydrolases | 1 | 2024 | 42 | 0.200 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2025 | 129 | 0.200 |
Why?
| | Protein Domains | 1 | 2025 | 315 | 0.200 |
Why?
| | Humans | 13 | 2026 | 146342 | 0.200 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2026 | 545 | 0.190 |
Why?
| | Models, Chemical | 2 | 2024 | 252 | 0.190 |
Why?
| | Animals | 5 | 2026 | 38106 | 0.170 |
Why?
| | Physiological Phenomena | 1 | 2021 | 3 | 0.170 |
Why?
| | Immunoglobulin Variable Region | 1 | 2021 | 78 | 0.170 |
Why?
| | Spectrum Analysis | 1 | 2021 | 85 | 0.170 |
Why?
| | Hydrogen Bonding | 1 | 2021 | 170 | 0.170 |
Why?
| | Enzyme Stability | 2 | 2017 | 74 | 0.160 |
Why?
| | Surface Properties | 1 | 2021 | 384 | 0.160 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2021 | 175 | 0.160 |
Why?
| | Proteins | 1 | 2026 | 1022 | 0.150 |
Why?
| | Influenza A virus | 1 | 2020 | 120 | 0.150 |
Why?
| | Quartz | 1 | 2019 | 9 | 0.150 |
Why?
| | Environment | 1 | 2021 | 299 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2017 | 533 | 0.150 |
Why?
| | Phosphopeptides | 1 | 2019 | 19 | 0.150 |
Why?
| | Pseudotsuga | 1 | 2018 | 1 | 0.140 |
Why?
| | Tannins | 1 | 2018 | 5 | 0.140 |
Why?
| | Cellulases | 1 | 2018 | 12 | 0.140 |
Why?
| | Titanium | 1 | 2019 | 74 | 0.140 |
Why?
| | Actinobacteria | 1 | 2017 | 15 | 0.130 |
Why?
| | Polyglycolic Acid | 1 | 2017 | 44 | 0.130 |
Why?
| | Protein Unfolding | 1 | 2017 | 34 | 0.130 |
Why?
| | Polystyrenes | 1 | 2017 | 38 | 0.130 |
Why?
| | Biological Evolution | 1 | 2021 | 471 | 0.130 |
Why?
| | Serum Albumin, Bovine | 1 | 2017 | 63 | 0.120 |
Why?
| | Polyesters | 1 | 2017 | 76 | 0.120 |
Why?
| | Bacillus subtilis | 1 | 2017 | 67 | 0.120 |
Why?
| | Mutagenesis | 1 | 2017 | 196 | 0.120 |
Why?
| | Eukaryota | 1 | 2016 | 56 | 0.110 |
Why?
| | Archaea | 1 | 2016 | 62 | 0.110 |
Why?
| | Lactic Acid | 1 | 2017 | 295 | 0.110 |
Why?
| | Models, Molecular | 1 | 2020 | 1573 | 0.110 |
Why?
| | Antibodies, Monoclonal | 1 | 2021 | 1512 | 0.100 |
Why?
| | Protein Stability | 2 | 2026 | 180 | 0.100 |
Why?
| | Phosphorylation | 1 | 2017 | 1724 | 0.100 |
Why?
| | Peptides | 1 | 2017 | 992 | 0.080 |
Why?
| | Nanoparticles | 1 | 2017 | 523 | 0.080 |
Why?
| | Time Factors | 1 | 2021 | 7109 | 0.080 |
Why?
| | Static Electricity | 2 | 2019 | 113 | 0.070 |
Why?
| | Lipid Droplets | 1 | 2026 | 24 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2026 | 74 | 0.060 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2026 | 106 | 0.060 |
Why?
| | Recycling | 1 | 2024 | 9 | 0.050 |
Why?
| | Drug Stability | 1 | 2021 | 172 | 0.040 |
Why?
| | Drug Approval | 1 | 2021 | 94 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2021 | 208 | 0.040 |
Why?
| | Kinetics | 1 | 2024 | 1553 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2021 | 410 | 0.040 |
Why?
| | Databases, Genetic | 1 | 2021 | 239 | 0.040 |
Why?
| | Mitochondria | 1 | 2026 | 997 | 0.040 |
Why?
| | Models, Genetic | 1 | 2021 | 540 | 0.040 |
Why?
| | Trichoderma | 1 | 2018 | 28 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2026 | 2502 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2018 | 121 | 0.030 |
Why?
| | Fungal Proteins | 1 | 2018 | 137 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2018 | 235 | 0.030 |
Why?
| | Electrolytes | 1 | 2017 | 52 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 563 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2017 | 192 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 940 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2025 | 17438 | 0.010 |
Why?
| | United States | 1 | 2021 | 16136 | 0.010 |
Why?
|
|
Sprenger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|